KDR and neoplasm: Given the critical role of neo‐angiogenesis in tumor growth, invasion and metastasis, drugs specific for angiogenic factors, such as vascular‐endothelial growth factor (VEGFR) and platelet‐derived growth factor receptor (PDGFR), are particularly promising for tumor control [6].